Cizzle Bio, Inc. is at the forefront of biotechnological innovation, dedicated to revolutionizing lung cancer detection through our pioneering CIZ1B biomarker blood test. Our mission is to improve early-stage lung cancer diagnosis, enhancing patient outcomes with non-invasive, highly accurate diagnostic solutions. In collaboration with Cizzle Biotechnology PLC, we utilize patented technologies to offer an effective alternative to traditional screening methods. With a focus on continuous innovation, strategic partnerships, and patient-centered care, we aim to make early cancer detection accessible and reliable for all.
Company Details
- Employees
- 7
- Address
- San Antonio, Tx 78248, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cizzlebio.com
- Keywords
- Lung Cancer Detection, Biomarker Research, Early Cancer Diagnosis, Non-Invasive Diagnostics, Biotechnology Innovation.
- HQ
- San Antonio, TX
Cizzle Bio, Inc. Questions
Cizzle Bio, Inc.'s website is https://www.cizzlebio.com
Cizzle Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cizzle-bio-inc
Cizzle Bio, Inc. has
7 employees.
View email and phone details for 7
employees at Cizzle Bio, Inc..
Cizzle Bio, Inc.'s industry is
Biotechnology Research
Cizzle Bio, Inc.'s top competitors are
Texas Biomedical Research Institute,
Healthgates®,
Cizzle Biotechnology Plc,
The Behnke Group,
Replimune,
Syantra Inc.,
Moffitt Cancer Center,
Olivon Advisors,
Mayo Clinic,
Alamo Biocenter.
Cizzle Bio, Inc.'s categories are Biotechnology Research
